Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 1, 2006, Pages 95-101

  Di Terlizzi, Simona ^a   Zino, Elisabetta ^a   Mazzi, Benedetta ^b   Magnani, Chiara ^a   Tresoldi, Cristina ^b   Perna, Serena Kimi ^b,c   Bregni, Marco ^b   Rossini, Silvano ^b   Ciceri, Fabio ^b   Bordignon, Claudio ^b,c   Bonini, Chiara ^b   Fleischhauer, Katharina ^a,b  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Graft versus leukemia activity; Hematopoietic stem cell transplantation; Host chimerism; Minimal residual disease; Minor histocompatibility antigens HA 1 and HA 2; Population study

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN HA 1; MINOR HISTOCOMPATIBILITY ANTIGEN HA 2; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER IMMUNOTHERAPY; CHIMERA; CONTROLLED STUDY; DISEASE MARKER; DONOR SELECTION; DRUG TARGETING; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MINOR HISTOCOMPATIBILITY COMPLEX; PATIENT MONITORING; PATIENT SELECTION; POPULATION RESEARCH; PROGNOSIS; SOLID TUMOR;

BIOLOGICAL MARKERS; EPIDEMIOLOGY, MOLECULAR; GENE FREQUENCY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; ITALY; LEUKEMIA, MYELOID; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASM PROTEINS; OLIGOPEPTIDES; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 29844456243     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.09.017     Document Type: Article

References (33)

1. E. Spierings B. Wieles E. Goulmy Minor histocompatibility antigens-big in tumour therapy Trends Immunol 25 2004 56-60
2. N.J. Chao Minors come of age: Minor histocompatibility antigens and graft-versus-host disease Biol Blood Marrow Transplant 10 2004 215-223
3. J.H. Falkenburg L. van de Corput E.W. Marijt R. Willemze Minor histocompatibility antigens in human stem cell transplantation Exp Hematol 31 2003 743-751
4. M. Bleakley S.R. Riddell Molecules and mechanisms of the graft-versus-leukaemia effect Nat Rev Cancer 4 2004 371-380
5. E. Goulmy Minor histocompatibility antigens: Allo target molecules for tumor-specific immunotherapy Cancer J 10 2004 1-7
6. L. Hambach E. Goulmy Immunotherapy of cancer through targeting of minor histocompatibility antigens Curr Opin Immunol 17 2005 202-210
7. J.M. den Haan L.M. Meadows W. Wang et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism Science 279 1998 1054-1057
8. J.M. den Haan N.E. Sherman E. Blokland et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen Science 268 1995 1476-1480
9. C.A. Klein M. Wilke J. Pool et al. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells J Exp Med 196 2002 359-368
10. M. Wilke J. Pool J.M. den Haan E. Goulmy Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR Tissue Antigens 52 1998 312-317
11. L.H. Tseng M.T. Lin P.J. Martin J. Pei A.G. Smith J.A. Hansen Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA Tissue Antigens 52 1998 305-311
12. R.A. Pierce E.D. Field T. Mutis et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein J Immunol 167 2001 3223-3230
13. T. Mutis R. Verdijk E. Schrama B. Esendam A. Brand E. Goulmy Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens Blood 93 1999 2336-2341
14. T. Mutis G. Gillespie E. Schrama J.H. Falkenburg P. Moss E. Goulmy Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease Nat Med 5 1999 839-842
15. B. Kircher S. Stevanovic M. Urbanek et al. Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion Br J Haematol 117 2002 935-939
16. W.A. Marijt M.H. Heemskerk F.M. Kloosterboer et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia Proc Natl Acad Sci U S A 100 2003 2742-2747
17. B. Kircher M. Wolf S. Stevanovic et al. Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion J Immunother 27 2004 156-160
18. F.M. Kloosterboer S.A. van Luxemburg-Heijs R.A. van Soest et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells Leukemia 18 2004 798-808
19. P. Brossart B. Spahlinger F. Grunebach et al. Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation Blood 94 1999 4374-4376
20. B. Wieles J. Pool R. Derks W.J. Burlingham E. Goulmy Detection of microchimerism by minor histocompatibility antigen HA-1 allele-specific nested polymerase chain reaction Biol Blood Marrow Transplant 11 2005 345-348
21. F.M. Heinemann S. Ferencik H.D. Ottinger D.W. Beelen H. Grosse-Wilde Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors Transplantation 77 2004 1103-1106
22. E.M. Kotzampasaki M.S. Spyropoulou-Vlachou C. Kalofoutis V. Vrani A. Kalofoutis C. Stavropoulos-Giokas Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation Transplant Proc 36 2004 1735-1738
23. C.A. van Els J. D'Amaro J. Pool et al. Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance Immunogenetics 35 1992 161-165
24. J.I. Arostegui D. Gallardo M. Rodriguez-Luaces et al. Genomic typing of minor histocompatibility antigen HA-1 by reference strand mediated conformation analysis (RSCA) Tissue Antigens 56 2000 69-76
25. M. Harangi W.E. Kaminski M. Fleck et al. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome Eur J Immunol 35 2005 305-317
26. M. Wilke J. Pool E. Goulmy Allele specific PCR for the minor histocompatibility antigen HA-2 Tissue Antigens 59 2002 304-307
27. A. Kimura T. Sasazuki Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique In: K.I. Tsuyi M. Aizawa T. Sasazuki eds. HLA 1991. Proceedings of Eleventh International Histocompatibility Workshop and Conference 1991 Oxford University Press Oxford, UK 397-419
28. J. Clayton C. Lonjou D. Whittle Allele and haplotype frequencies for HLA loci in various ethnic groups D. Charron HLA Genetic diversity of HLA Functional and Medical Implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference 1997 EDK Paris, France 665-820
29. S.M. Anderton D.C. Wraith Selection and fine-tuning of the autoimmune T-cell repertoire Nat Rev Immunol 2 2002 487-498
30. D. Cilloni G. Saglio WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome Acta Haematol 112 2004 79-84
31. M. Weisser W. Kern S. Rauhut Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia Leukemia 19 2005 1416-1423
32. M. Uzunel O. Ringden Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation Bone Marrow Transplant 33 2004 47-52
33. F. Khan A. Agarwal S. Agrawal Significance of chimerism in hematopoietic stem cell transplantation: New variations on an old theme Bone Marrow Transplant 34 2004 1-12